STAAR Surgical Revenue and Competitors
Estimated Revenue & Valuation
- STAAR Surgical's estimated annual revenue is currently $153.1M per year.
- STAAR Surgical received $6.8M in venture funding in May 2010.
- STAAR Surgical's estimated revenue per employee is $243,032
Employee Data
- STAAR Surgical has 630 Employees.
- STAAR Surgical grew their employee count by 6% last year.
STAAR Surgical's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman/CEO | Reveal Email/Phone |
2 | STAAR SURGICAL, VP, Global Finance | Reveal Email/Phone |
3 | Chief Clinical, Regulatory and Medical Affairs Officer | Reveal Email/Phone |
4 | Chief Clinical, Regulatory and Medical Affairs Officer | Reveal Email/Phone |
5 | Chief Legal Officer | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | VP, Global Head Consumer and Product Marketing | Reveal Email/Phone |
8 | VP Global Distributor Operations | Reveal Email/Phone |
9 | VP, Investor, Media Relations and Corporate Development | Reveal Email/Phone |
10 | VP, Global Clinical and Medical Affairs | Reveal Email/Phone |
STAAR Surgical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is STAAR Surgical?
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 30 years. The company offers the EVO Visian implantable Collamer® lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer Lens or "ICL". Nearly 600,000 Visian ICLs have been implanted to date. It also provides minimally invasive intraocular lenses (IOLs), including foldable IOLs for use in minimally invasive cataract surgical procedures; aspheric IOLs that produce a clearer image than traditional spherical lenses; nanoFLEX IOL, a single piece Collamer aspheric optic; and Toric IOLs for cataract patients, as well as preloaded injectors for use in cataract surgery. In addition, the company sells surgical products, and other related instruments and devices, as well as injector parts; and manufactures AquaFlow devices for the treatment of glaucoma. It markets its products to health care providers, including surgical centers, hospitals, managed care providers, health organizations, group purchasing organizations, and government facilities primarily under the STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, Epiphany, and AquaFlow trademarks. The company sells products directly through its sales representatives in the United States, Canada, Japan, Germany, the United Kingdom, and Spain, as well as through independent distributors in approximately 60 countries. STAAR Surgical Company was founded in 1982 and is headquartered in Monrovia, California.
keywords:Biotechnology,Hardware,Hardware Peripherals,Healthcare,Medical Devices,PharmaceuticalsN/A
Total Funding
630
Number of Employees
$153.1M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
STAAR Surgical News
STAAR Surgical saw strong revenue, margin and net income growth in 2021. The drop is part of a longer trend with STAAR's shares down more than...
STAAR Surgical (NASDAQ: STAA), which specializes in implantable lenses for the eye, saw its shares drop 12% this week, according to data...
STAAR Surgical has set its FY 2022 guidance at EPS.Individual that wish to listen to the company's earnings conference call can do so using this...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $344.2M | 745 | 57% | N/A |
STAAR Surgical Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2007-12-18 | $5.0M | Undisclosed | Article | |
2010-05-24 | $6.8M | Undisclosed | Article |